News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

XenoPort, Inc. (XNPT) Presents New Analyses Of Data For Gabapentin Enacarbil At The 33rd Annual Scientific Meeting Of The American Pain Society


4/30/2014 9:09:30 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

XenoPort, Inc. (Nasdaq: XNPT) announced today that it will present new analyses of data for gabapentin enacarbil (GEn), the active ingredient in HORIZANT® (gabapentin enacarbil) Extended-Release Tablets, at the 33rd Annual Scientific Meeting of the American Pain Society (APS) in Tampa, Florida.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES